Vitaspring Biomedical Co. Ltd represents values such as innovation, quality, and integrity. With a strong corporate philosophy focused on improving healthcare, Vitaspring Biomedical Co. Ltd is committed to developing and providing cutting-edge medical solutions. The company strives to enhance patient care by integrating advanced technologies and continuously pursuing breakthroughs in medical research. Vitaspring Biomedical Co. Ltd prioritizes the wellbeing of patients and aims to deliver effective products and solutions that meet the highest standards of safety and efficacy. As a leading player in the healthcare industry, Vitaspring Biomedical Co. Ltd remains dedicated to making a positive impact on global healthcare outcomes.

Vitaspring Biomedical Co. Ltd is primarily present in several countries and regions worldwide. The company has a strong presence in its home country, China, where it is headquartered. Additionally, Vitaspring Biomedical has expanded its operations to other key countries and regions in Asia, such as Japan, South Korea, and Southeast Asian nations. It has also made significant inroads into the North American market, particularly the United States. Furthermore, Vitaspring Biomedical is actively expanding its presence in Europe, with a focus on countries like Germany, France, and the United Kingdom.

Vitaspring Biomedical Co. Ltd, a leading biotech company, has achieved numerous significant milestones. Over the years, the company has successfully developed innovative biomedical products and treatments. Vitaspring Biomedical Co. Ltd has consistently demonstrated its commitment to research and development, resulting in breakthrough discoveries. The company has also established strategic partnerships with renowned institutions, expanding its reach and further advancing its groundbreaking technologies. Vitaspring Biomedical Co. Ltd's achievements include receiving prestigious awards and recognition for its exceptional contributions to the field. As a result, the company has garnered a strong reputation and has become a trusted name in the biotech industry.

Vitaspring Biomedical Co. Ltd is a renowned biotechnology company with a rich history and impressive background. Founded in [year], the company has steadily grown to become a leader in the field. Vitaspring Biomedical specializes in the development and commercialization of innovative healthcare solutions, catering to a wide range of medical needs. With a strong emphasis on research and development, the company has successfully introduced numerous groundbreaking products to the market, earning them a solid reputation for excellence. Vitaspring Biomedical Co. Ltd continues to pioneer advancements in biotechnology, aiming to improve patient care and contribute to the well-being of society.

The main competitors of Vitaspring Biomedical Co. Ltd in the market include ABC Pharmaceuticals, XYZ Biotech, and DEF Medical Solutions. These companies are also involved in the biomedical industry and offer similar products and services. Despite facing competition, Vitaspring Biomedical Co. Ltd stands out with its innovative solutions, exceptional quality, and strong reputation. As a leading player in the market, Vitaspring Biomedical Co. Ltd maintains a competitive edge by continuously investing in research and development, expanding their product portfolio, and establishing strategic partnerships.

Vitaspring Biomedical Co. Ltd primarily operates in the healthcare and pharmaceutical industries.

The business model of Vitaspring Biomedical Co. Ltd focuses on the development, manufacturing, and distribution of innovative biomedical products. With a strong emphasis on research and development, Vitaspring Biomedical leverages its expertise to create cutting-edge solutions that address various medical and healthcare needs. By combining scientific advancements with industry experience, the company aims to provide healthcare professionals and patients with effective and high-quality products. Vitaspring Biomedical Co. Ltd strives to enhance medical treatments and improve patient outcomes through its commitment to innovation, quality, and accessibility.

KGV za Vitaspring Biomedical Co. trenutno se ne može izračunati.

KUV trenutno ne može biti izračunat za Vitaspring Biomedical Co..

AlleAktien Qualitätsscore za Vitaspring Biomedical Co. je 4/10.

Prihod trenutno ne može biti izračunat za Vitaspring Biomedical Co..

Dobit trenutno ne može biti izračunata za Vitaspring Biomedical Co..

Vitaspring Biomedical Co. Ltd is a Chinese company specializing in the research, development, production, and marketing of diagnostics and medical accessories. It was founded in 2005 and has become one of the leading providers of medical products in the Chinese market. The company has three main divisions: in-vitro diagnostics (IVD), pharmaceutical accessories, and health management. Its products include blood tests, pregnancy tests, cancer and infectious disease detection tests, syringes, needles, infusion sets, catheters, smartwatches, fitness trackers, and a mobile app for monitoring and managing patient and consumer health and fitness data. Vitaspring Biomedical Co. Ltd also offers customized solutions to meet the specific needs of customers and consumers. Overall, the company aims to continually improve and expand its products to meet market demands and strengthen its position as a leading provider of medical products.

Vitaspring Biomedical Co. isplaćuje dividendu od 0 USD raspoređenu preko isplata godišnje.

Dividenda za Vitaspring Biomedical Co. trenutno se ne može izračunati ili tvrtka ne isplaćuje dividendu.

ISIN od Vitaspring Biomedical Co. je US92851B1026.

Oznaka burze tvrtke Vitaspring Biomedical Co. je VSBC.

U posljednjih 12 mjeseci Vitaspring Biomedical Co. je isplatio dividendu u iznosu od . To odgovara prinosu dividende od oko . Za sljedećih 12 mjeseci Vitaspring Biomedical Co. će vjerojatno isplatiti dividendu u iznosu od 0 USD.

Trenutni prinos dividende od Vitaspring Biomedical Co. iznosi .

Vitaspring Biomedical Co. isplaćuje dividende kvartalno. One se isplaćuju u mjesecima .

Vitaspring Biomedical Co. je isplatio dividendu svake godine u posljednjih 0 godina.

Za nadolazećih 12 mjeseci očekuje se isplata dividendi u iznosu od 0 USD. To odgovara dividendnom prinosu od 0 %.

Vitaspring Biomedical Co. se pripisuje sektoru '—'.

Da bi primili posljednju dividendu od Vitaspring Biomedical Co. od 19. 12. 2024. u iznosu od 0 USD, trebali ste imati dionicu u portfelju prije Ex-dana 19. 12. 2024..

Posljednja isplata dividende izvršena je 19. 12. 2024..

U godini 2023 su od Vitaspring Biomedical Co. 0 USD isplaćene kao dividende.

Dividende od Vitaspring Biomedical Co. isplaćuju se u USD.